Author:
Montrasio Giulia,Reiner Martin F.,Wiencierz Andrea,Aeschbacher Stefanie,Baumgartner Christine,Rodondi Nicolas,Kühne Michael,Moschovitis Giorgio,Preiss Helga,Coslovsky Michael,De Perna Maria L.,Bonati Leo H.,Conen David,Osswald Stefan,Beer Juerg H.,Koepfli Pascal
Funder
Swiss National Science Foundation
Subject
Pharmacology,Molecular Medicine,Physiology
Reference20 articles.
1. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials;Ruff;Lancet,2015
2. 2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist Oral anticoagulants in patients with atrial fibrillation;Steffel;EP Europace,2021
3. Inappropriate Doses of Direct Oral Anticoagulants in Real-World Clinical Practice: Prevalence and Associated Factors. A Subanalysis of the FANTASIIA Registry;Ruiz Ortiz,2017
4. ORBIT-AF Investigators and patients. Off-label dosing of non-vitamin K antagonist Oral anticoagulants and adverse outcomes: the ORBIT-AF II registry;Steinberg;J. Am. Coll. Cardiol.,2016
5. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study;Nielsen;BMJ.,2017
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献